|
Dr. Frenchick was appointed Vice President, Business Development in June 2007, bringing 10 years of experience in Business Development, 15 years in Technology assessment and project integration, and 20 years in biotechnology and biomedical research to the Company. Dr. Frenchick has held positions in major pharmaceutical companies and has also served as an independent consultant to them. Most recently, Dr. Frenchick was Vice President, Development for Combinature Biopharm AG, and prior to that he was Head of Portfolio Management, Corporate Business Development for Boehringer Ingelheim Vetmedica GmbH. Dr. Frenchick is an inventor on 8 issued patents, and he is a U.S. Registered Patent Agent. Dr. Frenchick received his B.S. and Ph.D. (Immunology) from the University of Minnesota, and an MBA from Queen’s University, Kingston Ontario, Canada. | 